Wells Fargo
IHE icon

Wells Fargo’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Wells Fargo’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.06M Buy
69,932
+19,025
+37% +$1.67M ﹤0.01% 2438
2025
Q4 		$4.32M Buy
50,907
+10,263
+25% +$819K ﹤0.01% 2817
2025
Q3 		$2.95M Sell
40,644
-3,826
-9% -$264K ﹤0.01% 3026
2025
Q2 		$2.91M Sell
44,470
-20,555
-32% -$1.34M ﹤0.01% 2910
2025
Q1 		$4.59M Buy
65,025
+5,145
+9% +$358K ﹤0.01% 2478
2024
Q4 		$3.94M Sell
59,880
-1,492
-2% -$103K ﹤0.01% 2628
2024
Q3 		$4.33M Buy
61,372
+1,428
+2% +$99.5K ﹤0.01% 2455
2024
Q2 		$3.98M Sell
59,944
-2,771
-4% -$182K ﹤0.01% 2436
2024
Q1 		$4.26M Sell
62,715
-2,553
-4% -$169K ﹤0.01% 2386
2023
Q4 		$4.03M Sell
65,268
-1,170
-2% -$68.8K ﹤0.01% 2372
2023
Q3 		$3.92M Sell
66,438
-5,478
-8% -$336K ﹤0.01% 2293
2023
Q2 		$4.29M Sell
71,916
-3,867
-5% -$230K ﹤0.01% 2273
2023
Q1 		$4.43M Sell
75,783
-140,547
-65% -$8.47M ﹤0.01% 2221
2022
Q4 		$13.4M Sell
216,330
-4,557
-2% -$274K ﹤0.01% 1360
2022
Q3 		$12.5M Buy
220,887
+6,549
+3% +$403K ﹤0.01% 1351
2022
Q2 		$13.7M Buy
214,338
+27,099
+14% +$1.72M ﹤0.01% 1359
2022
Q1 		$12.1M Buy
187,239
+7,626
+4% +$483K ﹤0.01% 1681
2021
Q4 		$12M Sell
179,613
-4,335
-2% -$275K ﹤0.01% 1715
2021
Q3 		$11.2M Buy
183,948
+2,826
+2% +$180K ﹤0.01% 2106
2021
Q2 		$11.2M Buy
181,122
+27,396
+18% +$1.67M ﹤0.01% 2138
2021
Q1 		$9.1M Buy
153,726
+90,177
+142% +$5.44M ﹤0.01% 2283
2020
Q4 		$3.8M Buy
63,549
+21,777
+52% +$1.24M ﹤0.01% 2986
2020
Q3 		$2.28M Buy
41,772
+9,261
+28% +$499K ﹤0.01% 3205
2020
Q2 		$1.67M Sell
32,511
-6,966
-18% -$350K ﹤0.01% 3399
2020
Q1 		$1.77M Sell
39,477
-4,497
-10% -$227K ﹤0.01% 3109
2019
Q4 		$2.35M Sell
43,974
-3,099
-7% -$153K ﹤0.01% 3223
2019
Q3 		$2.19M Sell
47,073
-21,888
-32% -$1.05M ﹤0.01% 3246
2019
Q2 		$3.47M Sell
68,961
-2,937
-4% -$145K ﹤0.01% 2880
2019
Q1 		$3.69M Sell
71,898
-25,200
-26% -$1.25M ﹤0.01% 2831
2018
Q4 		$4.56M Buy
97,098
+24,549
+34% +$1.26M ﹤0.01% 2525
2018
Q3 		$4.06M Sell
72,549
-3,684
-5% -$201K ﹤0.01% 2816
2018
Q2 		$3.85M Sell
76,233
-2,691
-3% -$133K ﹤0.01% 2921
2018
Q1 		$3.88M Sell
78,924
-7,569
-9% -$389K ﹤0.01% 2840
2017
Q4 		$4.45M Sell
86,493
-11,715
-12% -$602K ﹤0.01% 2678
2017
Q3 		$5.12M Sell
98,208
-666
-0.7% -$34.2K ﹤0.01% 2505
2017
Q2 		$5.11M Buy
98,874
+528
+0.5% +$26.7K ﹤0.01% 2427
2017
Q1 		$4.95M Buy
98,346
+8,217
+9% +$407K ﹤0.01% 2440
2016
Q4 		$4.25M Sell
90,129
-22,674
-20% -$1.08M ﹤0.01% 2533
2016
Q3 		$5.62M Sell
112,803
-22,065
-16% -$1.12M ﹤0.01% 2195
2016
Q2 		$6.49M Sell
134,868
-21,483
-14% -$1.02M ﹤0.01% 2131
2016
Q1 		$7.14M Sell
156,351
-241,839
-61% -$11.3M ﹤0.01% 2049
2015
Q4 		$21.5M Sell
398,190
-30,813
-7% -$1.62M 0.01% 1277
2015
Q3 		$21.2M Sell
429,003
-26,223
-6% -$1.5M 0.01% 1266
2015
Q2 		$26.5M Sell
455,226
-5,841
-1% -$341K 0.01% 1176
2015
Q1 		$26.5M Sell
461,067
-6,951
-1% -$380K 0.01% 1147
2014
Q4 		$23.6M Buy
468,018
+70,938
+18% +$3.46M 0.01% 1181
2014
Q3 		$18.6M Sell
397,080
-60,549
-13% -$2.73M 0.01% 1304
2014
Q2 		$20.6M Buy
457,629
+28,776
+7% +$1.24M 0.01% 1263
2014
Q1 		$18.1M Buy
428,853
+5,868
+1% +$246K 0.01% 1320
2013
Q4 		$16.7M Buy
422,985
+14,727
+4% +$553K 0.01% 1343
2013
Q3 		$14.5M Buy
408,258
+53,088
+15% +$1.87M 0.01% 1406
2013
Q2 		$11.8M Buy
+355,170
New +$11.8M 0.01% 1464

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Wells Fargo's IHE Position: Q1 2026 in Review

Wells Fargo increased its iShares US Pharmaceuticals ETF (IHE) stake by 37% in Q1 2026, buying an estimated $1.67M and bringing the position to 69,932 shares worth $6.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

Wells Fargo first reported a position in IHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.5M in Q2 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Wells Fargo held 69,932 shares of iShares US Pharmaceuticals ETF worth $6.06M as of Q1 2026.
  • Wells Fargo bought 19,025 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $1.67M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2438 holding.
  • Wells Fargo first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's iShares US Pharmaceuticals ETF position peaked at $26.5M in Q2 2015.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.